arrow
B

Bruno Sáinz

Department of Cancer Biology
H指数:49
被引数:7,725

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cells

基于适配体的MNK1抑制通过靶向癌细胞干细胞来减少胰腺导管腺癌的生长

2026-07-060
OAAI
A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma

二氧化硅纳米颗粒递送的CXCR4靶向肽可消除胰腺导管腺癌中的迁移癌干细胞

2026-04-010
PRE
c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT

c-Rel通过纤维连接蛋白-整合素信号通路诱导的隔离应激抵抗和EMT来驱动胰腺癌转移

2025-12-150
OAAI
A PGLYRP1-related signaling cascade initiated by cancer stem cells influences subtype identity in pancreatic ductal adenocarcinoma

PGLYRP1相关的信号级联由癌症干细胞启动,影响胰腺导管腺癌的亚型特性

2025-10-310
PRE
Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma

ARID1A突变胃肠道胰腺神经内分泌癌中,Aurora kinase A抑制作为一种合成致死策略。

2025-09-160
PREAI
TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis

TGF-β1介导的L1CAM在胰腺导管腺癌中的下调驱动了COL17A1和MMP2的上调,促进肿瘤侵袭和转移。

2025-08-060
OA
Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism

三维环境通过重编程能量代谢使胰腺癌细胞对布地奈德的抗增殖效应敏感

2024-06-140
OAAI
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy
2024-01-2710
OAAI
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new approach to treat pancreatic cancer
2024-01-161
PRE
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival

纳米医学和表观遗传学: 增加胰腺癌生存几率的新联盟

2023-09-019
OAAI
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment

针对MNK1的适体用于非小细胞肺癌的治疗

2023-04-183
OAAI
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical for KRAS mutant cancer
2022-11-0122
OAAI
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
2022-10-2626
OAAI